• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of a combined behavioral and pharmacological program on weight loss.

作者信息

Brightwell D R, Naylor C S

出版信息

Int J Obes. 1979;3(2):141-8.

PMID:528125
Abstract

The effects of an 'anorectic' drugs as an adjunct to a behavioral weight-loss programme were investigated. Four groups of 20 began an initial two weeks of instruction. Groups 1, 2, and 3 were instructed in a behavioral programme utilizing a food diary, stimulus control techniques, and reinforcement. Group 4 was instructed in a relaxation programme. Group 1 took phentermine resin 30 mg for eight weeks, followed by a placebo for eight. Group 2 took placebo for eight and phentermine for eight. Group 3 took placebo for 16. Group 4 took placebo for eight and phentermine for eight. All groups were followed for an additional eight weeks. A significant number of subjects in all behavioral groups achieved some weight loss. (A significant difference among the mean percentage body weight reduction for the three behavioral groups was also found.) In addition, a group of 'slow losers' who initially lost less than one half-pound (0.2 kg) per week and were subsequently placed on phentermine lost significantly more weight than a similar group which continued on placebo. These differences were maintained for 24 weeks.

摘要

相似文献

1
Effects of a combined behavioral and pharmacological program on weight loss.
Int J Obes. 1979;3(2):141-8.
2
A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.一项关于体重控制的双盲临床试验。单独及联合使用芬氟拉明和苯丁胺。
Arch Intern Med. 1984 Jun;144(6):1143-8.
3
Long-term weight control study. IV (weeks 156 to 190). The second double-blind phase.
Clin Pharmacol Ther. 1992 May;51(5):608-14. doi: 10.1038/clpt.1992.72.
4
Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise.
Clin Pharmacol Ther. 1992 May;51(5):595-601. doi: 10.1038/clpt.1992.70.
5
Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo.
Clin Pharmacol Ther. 1992 May;51(5):586-94. doi: 10.1038/clpt.1992.69.
6
Effects on weight reduction and safety of short-term phentermine administration in Korean obese people.短期服用苯丁胺对韩国肥胖人群体重减轻及安全性的影响。
Yonsei Med J. 2006 Oct 31;47(5):614-25. doi: 10.3349/ymj.2006.47.5.614.
7
Plasma phentermine levels, weight loss and side-effects.
Int J Obes. 1983;7(6):591-5.
8
Psychological treatment of obesity with phentermine resin as an adjunct.
Am J Psychiatry. 1978 Aug;135(8):936-9. doi: 10.1176/ajp.135.8.936.
9
Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
Curr Ther Res Clin Exp. 1972 Nov;14(11):726-38.
10
Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.在一项多中心试验中,普兰林肽与西布曲明或 phentermine 联合使用可增强减肥效果。
Obesity (Silver Spring). 2010 Sep;18(9):1739-46. doi: 10.1038/oby.2009.478. Epub 2010 Jan 21.

引用本文的文献

1
Obesity. A report of the Royal College of Physicians.肥胖症。皇家内科医师学院报告。
J R Coll Physicians Lond. 1983 Jan;17(1):5-65.